Johns Hopkins Medicine’s Post

Assessing patients’ genetics has become key to prescribing personalized interventions in a variety of diseases — most notably cancer, in which targeted treatments for specific genetic variants have significantly improved prognoses. However, the genetics revolution has yet to reach Crohn’s disease, a condition that affects more than 1 million Americans, says gastroenterologist Dr. Joanna Melia. https://bit.ly/3E71yoP

Research Shows Promise for Personalized Medicine in Crohn's Disease

Research Shows Promise for Personalized Medicine in Crohn's Disease

hopkinsmedicine.org

New research, linking a genetic mutation in Crohn's disease patients to disrupted bile acid metabolism, can open the door to using existing drugs for targeted treatment. This discovery brings us closer to personalized medicine & improve treatment outcomes.

Ernst Snyman

Family practitioner at Smith Clinic and St Mary hospital

1w

An important and disease outcome changing opportunity. Thanks

See more comments

To view or add a comment, sign in

Explore topics